Profound Medical (PROF) Receivables - Net (2018 - 2026)

Profound Medical's Receivables - Net history runs 9 years deep, the most recent figure standing at $9.4 million for Q1 2026.

• In Q1 2026, Receivables - Net rose 57.95% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at $9.4 million (up 57.95% YoY), while the FY2025 annual figure was $7.2 million, up 2.2% from the prior year.
• Receivables - Net was $9.4 million for Q1 2026 at Profound Medical, up from $7.2 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $9.4 million in Q1 2026 to a low of $3.0 million in Q4 2023.
• Historically, Receivables - Net has averaged $6.4 million across 5 years, with a median of $6.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Receivables - Net sank 51.95% in 2023, then soared 131.14% in 2024.
• A 5-year view of Receivables - Net shows it stood at $6.3 million in 2022, then tumbled by 51.95% to $3.0 million in 2023, then soared by 131.14% to $7.0 million in 2024, then grew by 2.2% to $7.2 million in 2025, then surged by 30.88% to $9.4 million in 2026.
• The last three Receivables - Net figures came in at $9.4 million (Q1 2026), $7.2 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.